Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-027566
Filing Date
2017-11-29
Accepted
2017-11-29 18:39:55
Documents
1
Period of Report
2017-11-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5889
  Complete submission text file 0000899243-17-027566.txt   7397
Mailing Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130 858-792-6300
MEI Pharma, Inc. (Issuer) CIK: 0001262104 (see all company filings)

EIN.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MARSHALL EDWARDS, INC. 11975 EL CAMINO REAL, SUITE 101 SAN DIEGO CA 92130
Business Address
Baltic Charles V. III (Reporting) CIK: 0001533340 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50484 | Film No.: 171229611